Business Wire

Conrad New York Midtown Debuts in the Heart of Manhattan

Share

Conrad Hotels & Resorts, Hilton’s (NYSE:HLT) global luxury hotel brand, today announced the grand opening of the 54-floor, 562-suite Conrad New York Midtown, adding to its extensive portfolio of luxury hotels around the world. This is the brand’s second New York City property and is located at 151 West 54th St., the former site of The London NYC.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191001006051/en/

Penthouse on 54 (Photo: Conrad New York Midtown)

Penthouse on 54 (Photo: Conrad New York Midtown)

Following a complete hotel renovation, guest suites more closely resemble a metropolitan pied-a-terre than a traditional NYC hotel room. Design elements, programming and curation of the hotel are innately residential, inviting guests to experience what it would feel like to live in Manhattan.

“We are thrilled to expand our portfolio of luxury hotels in the Americas with the opening of the Conrad New York Midtown,” said Danny Hughes, executive vice president and president, Americas, Hilton. “As travel to New York City continues to grow, this hotel’s prime location, large suites, curated art collection and culinary offerings will give global business and leisure travelers a new luxury option in the heart of Manhattan.”

Celebrated hospitality design firm Stonehill Taylor designed the hotel as an expression of calm elegance – grand, lavish and comfortable.

Only Suites

A jewel-tone color palette, custom-designed furniture, herringbone wood floors, hand-tufted wool rugs and Carrera marble bathrooms comprise generous floor plans, ranging from 500 square-foot one-bedroom suites to a 3,000 square-foot, two-story penthouse.

Thirteen premium suites provide guests with a distinct style of living:

  • Penthouse on 54 (3,000 square feet) is a two-story, two-bedroom suite. The first floor entertaining and living area has wrap-around views of Central Park and Manhattan; a fireplace; an original Eames chair; and a custom-designed bold red sofa inspired by nearby and soon-to-reopen Museum of Modern Art (MoMA). A floating staircase leads to two spacious master bedrooms with luxurious king beds, walk-in closets and marble-clad bathrooms with deep soaking tubs, all boasting views of the surrounding city.
  • The one-bedroom Atrium Suite (1,200 square feet) is perched 43 stories high with a portion of the living area housed within a greenhouse-like glass enclosure, revealing panoramic views of Manhattan. Pale pink, dark green, blue and grey-toned hues play upon the passing of seasons of Central Park visible below.
  • Five Apartment Suites (1,400-1,700 square feet) offer separate dining rooms, spacious living rooms and a study with artful books. One Apartment Suite offers a full kitchen.
  • Six Sky Suites (900 square feet) reside on the top floors of Conrad New York Midtown and are designed with open layouts that incorporate a study, dining and living rooms as well as king-size bedrooms.

“We are incredibly proud and excited for the Conrad New York Midtown to open as our second property in New York City,” said Martin Rinck, executive vice president and global head, Luxury & Lifestyle Group, Hilton. “The Conrad New York Midtown has a contemporary design that when paired with personalized, intuitive service will truly inspire the globally connected traveler.”

Conrad New York Midtown, whose former identity was rooted in hosting Hollywood notables, will carry on its legacy as a major player in the press junket arena. The hotel has integrated state-of-the-art technology to create a fully-wired junket floor with four television shooting suites, green room and control room – all designed to meet the needs of the entertainment industry.

Contemporary Art

Conrad New York Midtown is home to an extensive art collection featuring references to Abstract Expressionism, Pop Art, street photography, jazz improvisation and pulling inspiration from art institutions such as Broadway theater, MoMA, the Guggenheim and the Metropolitan Museum of Art in new guises throughout the hotel.

Curated by boutique art consultancy VISTO, Conrad New York Midtown’s collection is inspired by NYC’s art, culture and nearby world-class museums. Pivotal art movements are represented and reinterpreted in the collection, including the crown jewel of the portfolio anchored in the center of the hotel’s lobby: Leda and the Swan. A life-like sculpture by renowned hyperrealist contemporary artist Carole A. Feuerman, the piece depicts the Greek myth of the same name, reinterpreting the tale to exhibit Leda in a position of power over Zeus. This permanent installation serves as the hallmark of the hotel’s broad collection which features 37 artists and includes an original Henri Matisse lithograph, two original Andy Warhol silkscreens and two limited-edition photographs by Amy Judd.

Elevated Amenities

Thoughtful amenities nodding to local experiences are a focus for Conrad New York Midtown:

  • In partnership with Truman’s Gentlemen's Groomers, the local premiere men’s grooming lounge, guests enjoy exclusive treatment packages and reserve pours from the private bar. Penthouse guests receive a complimentary, in-room straight-razor shave.
  • The hotel offers Dyson Supersonic™ Hair Dryers standard for premium suites guests. All guests interested in experiencing Dyson hair care technology at the hands of Dyson stylists are invited to enjoy complimentary washes and blowouts at the nearby 5th Avenue flagship Dyson Demo Store, based upon availability.
  • Given the proximity to Carnegie Hall and Broadway, the hotel offers in-suite live entertainment, such as a private performance by a classically trained solo musician, that can be booked through the concierge. In the Penthouse on 54 guests can enjoy a complimentary 30-minute performance with their stay, be it a cellist performing during a dinner party or a harpist strumming a live lullaby.
  • The hotel’s in-room dining options include luxe caviar tastings from nearby and globally famed caviar purveyor Petrossian. Guests receive exclusive luxuries at the restaurant and retail shop just a few blocks away, as well as complimentary Petrossian surprises from time to time.

“It’s nothing short of an honor to build upon the legend that this hotel has created in Midtown,” said Robert H. Rechtermann, general manager, Conrad New York Midtown. “This opening not only celebrates our neighborhood’s and building’s past, but also ushers in a new era of luxury in the heart of Manhattan. We can’t wait to serve today’s generation of travelers by offering unprecedented service, comforts and experiences that are synonymous with the Conrad Hotels & Resorts name.”

Additional amenities include: use of the hotel’s luxury house car; a choice between luxury bath amenities (Shanghai Tang, Temple Spa or Refinery); digital check-in, digital key and digital check-out through the Hilton Honors app; laundry services; pet amenities; 24/7 business center access; and valet parking.

Delights at Dabble

Offset from the hotel’s lobby is Dabble, a signature dining destination offering light fare and classic cocktails. During the day, Dabble offers an approachable menu – executed by Executive Chef Sani Hebaj, former Executive Chef at The Plaza Hotel – featuring shareable small plates and larger entrees such as Hebaj’s signature Long Island Duck with baby kale and plum compote and a Summer Vegetable Pot Pie with petite green salad.

Dabble’s bar program showcases expertly prepared cocktails, including classic staples and avant-garde craft offerings. There is a strong emphasis on presentation, including smoked cocktails, theatrical tableside preparations, molecular gastronomy, unconventional serving vessels and garnishes branded with the Conrad Hotels & Resorts seal.

Adjacent to Dabble, guests will find Plume, the hotel’s private dining room and event space accommodating up to 100 guests for a cocktail-style reception and 75 for a seated dinner. These offerings join the hotel’s six additional private meeting and event spaces throughout the property.

As part of Hilton, Conrad New York Midtown participates in Hilton Honors, the award-winning guest-loyalty program for Hilton's 17 distinct hotel brands. Members who book directly have access to instant benefits, including a flexible payment slider that allows members to choose nearly any combination of Points and money to book a stay at an exclusive member discount.

Nightly rates average $550 per night. To book a reservation at Conrad New York Midtown, please call (212) 307-5000 or visit www.conradnewyorkmidtown.com.

ABOUT CONRAD HOTELS & RESORTS

Spanning five continents with 35 properties, Conrad Hotels & Resorts has created a seamless connection between contemporary design, leading innovation and curated art to inspire the entrepreneurial spirit of the globally connected traveler. Conrad is a place where guests can experience service and style on their own terms – all while connecting with local and global culture. Connect with Conrad by booking at www.conradhotels.com or through the Hilton Honors mobile app. Learn more about the brand by visiting newsroom.hilton.com/conradhotels, and follow us on Facebook, Instagram, and Twitter.

ABOUT HILTON

Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 17 world-class brands comprising nearly 5,900 properties with more than 939,000 rooms, in 114 countries and territories. Dedicated to fulfilling its mission to be the world’s most hospitable company, Hilton earned a spot on the 2018 world’s best workplaces list and has welcomed more than 3 billion guests in its 100-year history. Through the award-winning guest loyalty program Hilton Honors, more than 94 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy, plus enjoy instant benefits, including digital check-in with room selection, Digital Key, and Connected Room. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook, Twitter, LinkedIn, Instagram and YouTube.

ABOUT STONEHILL TAYLOR

Stonehill Taylor is a hospitality-focused architecture and interior design firm based in New York City. The firm's approach to designing destinations is to create an inspired and distinct reflection on the location, space, history and culture for each project. Stonehill Taylor's distinguished portfolio in interior design and architecture includes TWA Hotel, The Whitby, Moxy Chelsea, Ace Hotel New York, The Refinery Hotel, InterContinental Barclay, JW Marriott Nashville, and the Eliza Jane Hotel in New Orleans. Stonehill Taylor is at the forefront of sustainable design, developing projects that are conscious of their impact on local communities and the world such as: The Crosby Street Hotel, The NoMad Hotel and Nomad Las Vegas, and Portland’s Press Hotel. For more information, visit: www.stonehilltaylor.com.

Press Assets:

Images are available here, credited to Conrad New York Midtown.

Contact information

Senka Suljic-Sosa, senka.suljic-sosa@conradhotels.com

The Door | conradny@thedooronline.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Idriverplus Joins the “Automate with Velodyne” Ecosystem29.5.2020 20:31:00 CESTPress release

Velodyne Lidar, Inc. and Idriverplus today announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. Through the program, Velodyne will further collaborate with Idriverplus to support its continued innovation and promote Idriverplus autonomous vehicles, including street cleaners, passenger cars and logistics vehicles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200529005589/en/ Velodyne Lidar, Inc. and Idriverplus announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. (Photo: Velodyne Lidar) Recently, Velodyne signed a multi-year sales agreement with Idriverplus to provide Puck™ sensors for the mass production of autonomous vehicles. Idriverplu

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS29.5.2020 14:00:00 CESTPress release

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56thAmerican Society of Clinical Oncology (ASCO) Annual Meeting and the virtual 25thEuropean Hematology Association (EHA) Annual Meeting. The study evaluated pevonedistat plus azacitidine versus azacitidine alone in patients with rare leukemias, including higher-risk myelodysplastic syndromes (HR-MDS). These results show that the combination of pevonedistat and azacitidine is a highly active, promising therapeutic approach and suggest benefit in the HR-MDS subgroup across multiple clinically meaningful endpoints, including overall survival (OS), event-free survival (EFS), complete remission (CR) and transfusion independence, with a safety profile similar to azacitidine alone. The Pevonedistat-2001 trial was designed as a proof-of-concept study in patients with HR-MDS, higher-risk chronic myelomonocytic leukemi

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO ® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks29.5.2020 14:00:00 CESTPress release

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on a Type II Variation regulatory application and recommended the approval of a pre-filled syringe presentation of TAKHZYRO® (lanadelumab). TAKHZYRO is a subcutaneous injectable prescription medication approved in Europe for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. HAE is a rare genetic disorder that results in recurrent attacks of oedema – swelling – in various parts of the body, including the abdomen, face, feet, genitals, hands and throat.1,2,3 “Our goal is to continuously innovate in all areas of HAE management,” said Isabel Kalofonos, Global Product Strategy Lead, HAE, Takeda. “This positive opinion marks another important step forward as we aim to enhance the experience of treatment administration for peo

Interim Data from the Open Label Phase 2 OPTIC Study of Iclusig ® (ponatinib) for Chronic Phase-CML Presented at the ASCO and EHA Virtual Meetings29.5.2020 14:00:00 CESTPress release

Incyte (Nasdaq:INCY) today announced that data from the interim analysis of the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial, which was sponsored by Takeda and co-funded by Incyte, will be presented during an oral session at the upcoming 2020 American Society of Clinical Oncology Virtual Meeting (ASCO20; May 29 – May 31) (Abstract #7502)1; and at the virtual 25th Congress of the European Hematology Association (EHA25; June 11 – 14) (Abstract #S172)2. The OPTIC trial is an ongoing randomized, open-label study prospectively evaluating response-based dosing regimens of Iclusig® (ponatinib) over a range of three starting doses (45 mg, 30 mg, 15 mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML), who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow up of approximately 21 months, data from the interim analysis of the OPTIC trial show that the optimal benefit-r

Takeda to Present Data from the ICLUSIG ® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML29.5.2020 14:00:00 CESTPress release

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that interim analysis data from the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial will be presented during an oral session at the virtual 56thAmerican Society of Clinical Oncology (ASCO) Annual Meeting and the 25thEuropean Hematology Association (EHA) Annual Meeting. The OPTIC trial is an ongoing, randomized, open-label study prospectively evaluating response-based dosing regimens of ICLUSIG® (ponatinib) over a range of three starting doses (45-, 30-, or 15-mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML) who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow-up of approximately 21 months, data from the interim analysis of OPTIC show that the optimal benefit-risk profile for ICLUSIG in patients with CP-CML is achieved with a daily starting dose of 45-mg and, upon achieving ≤1% BCR-A

LetsGetChecked Debuts FDA EUA-Authorized At-Home Coronavirus (COVID-19) Sure-track Test29.5.2020 13:57:00 CESTPress release

LetsGetChecked, the leading direct-to-consumer at-home health testing and insights company, announces today the authorization of the new Coronavirus (COVID-19) Sure-track Test for at-home consumer use by the U.S. Food and Drug Administration under an EUA. The new test is authorized to serve at-risk individuals with a proprietary at-home PCR nasal swab test that delivers accurate and definitive results within 24 hours. Offering an end-to-end model, LetsGetChecked’s new Sure-track Test introduces the most complete FDA EUA-authorized Coronavirus at-home testing solution. The at-home Coronavirus (COVID-19) test incorporates a nasal swab and PCR lab analysis, offering convenient and secure results in 24 hours. Unlike serology tests that detect the presence of antibodies, the at-home COVID-19 test determines the presence or absence of SARS-CoV-2 viral RNA. LetsGetChecked’s Sure-track Test is the only FDA EUA-authorized at-home Coronavirus (COVID-19) test that owns all aspects of the testing